These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12635373)

  • 1. [Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy].
    Ionescu SD; Sandru V; Leuciuc E; Manea P; Burdujan A; Tovarniţchi S; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):128-31. PubMed ID: 12635373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
    Dietz R; Nagel F; Osterziel KJ
    Verh Dtsch Ges Inn Med; 1991; 97():545-8. PubMed ID: 1667051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hospital intensive monitoring of adverse reactions of ACE inhibitors].
    Mangrella M; Motola G; Russo F; Mazzeo F; Giassa T; Falcone G; Rossi F; D'Alessio O; Rossi F
    Minerva Med; 1998 Apr; 89(4):91-7. PubMed ID: 9676174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotension after first-dose ACE inhibitor administration in heart failure--should doctors stop worrying?
    Remme WJ
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):475-7. PubMed ID: 11916355
    [No Abstract]   [Full Text] [Related]  

  • 7. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitors and cough--a north Indian study.
    Singh NP; Uppal M; Anuradha S; Agarwal A; Rizvi SN
    J Assoc Physicians India; 1998 May; 46(5):448-51. PubMed ID: 11273288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors and the otolaryngologist.
    Cruickshank HE
    Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):189-91. PubMed ID: 7554324
    [No Abstract]   [Full Text] [Related]  

  • 10. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
    Woo KS; Nicholls MG
    Br J Clin Pharmacol; 1995 Aug; 40(2):141-4. PubMed ID: 8562296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of lysinopril in cardiac insufficiency].
    Lambert M; Luccioni R
    Rev Prat; 1990 Oct; 40(23 Suppl):53-8. PubMed ID: 2176346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of patch tests for diagnosing selective allergy to captopril.
    Gaig P; San Miguel-Moncin MM; Bartra J; Bonet A; García-Ortega P
    J Investig Allergol Clin Immunol; 2001; 11(3):204-6. PubMed ID: 11831455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with lisinopril. Observations on safety and tolerability.
    Cameron HA; Higgins TJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():177-86. PubMed ID: 2550641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA; Murray KM
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.
    Gantenbein MH; Bauersfeld U; Baenziger O; Frey B; Neuhaus T; Sennhauser F; Bernet V
    J Perinat Med; 2008; 36(5):448-52. PubMed ID: 18605972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.